REG - Feedback PLC - Grant of Options and PDMR dealing

FeedbackAnnouncement

22/04/2026 14:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260422:nRSV5314Ba&default-theme=true

RNS Number : 5314B  Feedback PLC  22 April 2026

Feedback plc

 

Grant of Options and PDMR dealing

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical
infrastructure specialist, announces that it has granted a total of 438,148
options to subscribe for new ordinary shares of 1 penny each in the Company
("Ordinary Shares") under the Company's EMI Share Option Scheme (the
"Options") to Emma Oswick, Chief Financial Officer as detailed below.

 

The Options are being issued to appropriately incentivise management, as well
as to ensure their interests are aligned with that of the Company and its
Shareholders. The Options are exercisable at 20 pence per share.  This price
reflect the price at which the Company last completed an equity fundraise in
November 2024 and represents a premium of 105% per cent to the closing share
price on the last trading day before this announcement.

 

The Options will vest in four equal tranches as follows:

 

·      25% vest in three equal sub-tranches annually (8.33% on each of
the first, second and third anniversary of grant of 22(nd) April 2026)

·      25% vest on reported revenue of £8m

·      25% vest on reported revenue of £12m; and

·      25% vest on reported revenue of £20m

 

"Reported Revenue" is either:

 

·      a year's revenue reported in the full year audited financial
statements; or

·      12 months' revenue being H2 of the last full year audited
financial statements plus H1 of the last published interim financial
statements.

 

The Options are exercisable for a period of 5 years from the vesting date.

 

Following the grant of Options, Emma Oswick will hold a total interest in the
Company of 438,148 options.  The Options represent in aggregate 1.0% of the
Company's existing issued share capital.

 

Following the grant of the Options and taking into account existing options,
the Company has a total of 4,481,061 options to subscribe for ordinary shares
in the Company in issue, representing 10.2% of the Company's issued share
capital at the date of this announcement.

 

 

Further information on Feedback and its products can be found on the Company's
website: https://feedbackmedical.com (https://feedbackmedical.com/)

 

--Ends--

Enquiries:

 

 Feedback plc                                +44 (0) 20 3997 7634

 Tom Oakley, CEO                             IR@fbk.com (mailto:IR@fbk.com)

 Emma Oswick, CFO

 Panmure Liberum Limited (NOMAD and Broker)  +44 (0)20 7886 2500

 Emma Earl/Mark Rogers (Corporate Finance)

 Rupert Dearden (Corporate Broking)

 Walbrook PR Ltd;                            Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
                                             (mailto:feedbackplc@walbrookpr.com)
 Nick Rome/Marcus Ulker                      07748 325 236 or 07867 984 082

 

 

About Feedback plc

 

Feedback plc is the strategic partner to unlock productivity in health and
care through digital connectivity and asynchronous collaboration. With proven
expertise in system integration, we enable teams to work flexibly, share
information securely, and deliver care more efficiently.

 

Bleepa® is an award-winning collaboration platform that improves the quality
and productivity of patient pathways enabling health and care organisations to
hit targets with their existing clinical workforce. We achieve this by
connecting digital infrastructure across systems, enabling asynchronous
working, reducing geographic barriers and removing unnecessary appointments.

 

Bleepa supports the shift from analogue to digital and from hospital to
community-based care, by uniting essential data and teams to enhance clinical
decision making and enable better coordinated care.

 

The Company has a number of growth opportunities domestically and
internationally across a range of public and private healthcare markets
including the NHS. Our highly scalable software-as-a-service (SaaS) based
model is expected to provide increasing levels of revenue visibility as the
Company grows its customer base.

 

https://fbk.com (https://fbk.com)

 

 

Notification and public disclosure of transactions by Persons Discharging
Managerial Responsibilities under UK MAR

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Emma Oswick

 2    Reason for the notification

 a)   Position/status                                              PDMR - Chief Financial Officer

 b)   Initial notification /Amendment                              Initial

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Feedback plc

 b)   LEI                                                          213800UGOF2GT2U2RV90

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares of 1 penny each

      Identification code

                                                                   GB00BJN59X09
 b)   Nature of the transaction                                    Grant of options to subscribe for Ordinary Shares

 c)   Price(s) and volume(s)                                       Price(s)  Volume(s)

                                                                   Nil       438,148

 

 d)   Aggregated information

      - Aggregated volume                                          N/A

      - Price
 e)   Date of the transaction                                      22(nd) April 2026

 f)   Place of the transaction                                     Outside a trading venue

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

 

N/A

 

e)

 

Date of the transaction

 

22(nd) April 2026

 

f)

 

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCXLLFLQZLBBBV



            Copyright 2019 Regulatory News Service, all rights reserved